Skip to main navigation
Skip to content
  • News
  • Careers
  • Open Positions
C4 Therapeutics C4 Therapeutics
  • About Us Expand
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
    • Partnerships & Collaborations
    • Quality Policy Statement
  • Our Science Expand
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnerships & Collaborations
    • Quality Policy Statement
  • Pipeline
  • Investors Expand
    • Overview
    • Press Releases
    • Events & Presentations
    • Scientific Publications
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Corporate Governance
    • Email Alerts
    • Contact IR
    • FAQ
C4 Therapeutics

SEC Filing Details

    Investors

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
  • Analyst Coverage
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Contact IR
  • FAQ
Menu

    Investors

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
  • Analyst Coverage
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Contact IR
  • FAQ

SEC Filing Details

Document Details

Form
8-K
Filing Date
Aug 4, 2022
Document Date
Aug 4, 2022
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
C4 Therapeutics
Issuer
C4 Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
XML - XBRL INSTANCE DOCUMENT

Toolkit

Linkedin-in
Twitter
Phone

617-231-0700

Location

490 Arsenal Way, Suite 120 Watertown, MA 02472

Email

info@c4therapeutics.com

© 2023 C4 Therapeutics, Inc.
Privacy Policy       Terms of Use Agreement        Sitemap
Scroll to top
Search
  • About Us
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
    • Partnerships & Collaborations
    • Quality Policy Statement
  • Our Science
    • Overview
    • Targeted Protein Degradation
    • C4T TORPEDO™ Platform
    • aTAG Open Source Program
    • Scientific Publications
  • Pipeline
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Scientific Publications
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Corporate Governance
    • Email Alerts
    • Contact IR
    • FAQ
  • News
  • Careers
  • Open Positions

Search